“It Will Make CTE a Treatable Disease”: The Race for a Diagnosis in Life
When you’re not feeling yourself, you hope your doctor can provide some answers. Maybe they can tell you what’s wrong, why it’s happening, and what can be done about it. Or, if they can’t zero in on a diagnosis, perhaps tests—blood work, scans, samples—can help fill in the gaps. But what if a diagnosis never […]
4th Annual FHS-BAP Virtual Symposium on “Inflammation, Immunity, and Alzheimer’s Disease: From Mechanisms to Potential Therapeutics”
May 10, 2024 Sponsored by BU Alzheimer’s Disease Center, BU Evans Center for Interdisciplinary Biomedical Research, American Heart Association, and the Framingham Heart Study Brain Aging Program.
‘A living hell inside of my head’: For first time, more advanced stage of CTE diagnosed in teen football player
November 20, 2023 (CNN) In July 2019, just months after graduating from high school, 18-year-old Wyatt Bramwell took his own life. About a year later, researchers at Boston University diagnosed him with stage 2 chronic traumatic encephalopathy, known as CTE, caused by playing tackle football for several years. Playing football may increase risk of Parkinson’s […]
Dr. Rhoda Au Receives Prestigious Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Development
September 20, 2023 The Alzheimer’s Drug Discovery Foundation’s Goodes Prize supports researchers transforming the field by translating the biology of aging into new therapeutics and diagnostic tools NEW YORK, Sept. 20, 2023 /PRNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF) has presented Rhoda Au, PhD, MBA, Professor of Anatomy and Neurobiology at the Boston University Chobanian and Avedisian School of […]
Dr. Richard Sherva | BU Precision Med in AD ARC Lecture Series
November 8, 2023 Dr. Richard Sherva presented,” Genetic factors modulating both susceptibility to chronic viral infections and their effect on AD risk”. Dr. Sherva is an associate professor in the Department of Medicine in the Biomedical Genetics section at Boston University.
Dr. Benjamin Woolozin | BU Precision Med in AD ARC Lecture Series
September 13, 2023 Dr. Benjamin Woolozin presented, “RNA Methylation: A New Biomarker in AD”. Dr. Wolozin is a professor of pharmacology and neurology as well as a member of the Center for Systems Neuroscience and the Neurophotonics Center at Boston University in Massachusetts.
Dr. Gyungah Jun | BU Precision Med in AD ARC Lecture Series
October 11, 2023 Dr. Jun presented, “Our Contribution to APOE Research for Alzheimer’s Disease: Past, Current, and Future” Dr. Jun is a globally renowned Alzheimer’s disease (AD) geneticist and an expert in analysis of “big data”. She is an associate professor in the Department of Medicine in the Biomedical Genetics section at Boston University.
3rd Annual FHS-BAP Virtual Symposium on Biomarkers and Translational Approaches to Alzheimer’s Disease and Related Disorders
April 11, 2023 Sponsored by BU Alzheimer’s Disease Center, BU Evans Center for Interdisciplinary Biomedical Research, American Heart Association, and the Framingham Heart Study Brain Aging Program.